Energy Co. Gains Raised Target Price After Announcement
Source: Kirk Wilson 01/27/2025
NG Energy International Corp. (GASX:TSX.V; GASXF:OTC; 56P:FRA) received a raised target price from Beacon Securities after it announced a US$150 million sale of a 40% working interest in its Sinu-9 Block to Maurel & Prom (M&P).
In a January 21, 2025 research note, Beacon Securities analyst Kirk Wilson maintained a Buy rating on NG Energy International Corp. (GASX:TSX.V; GASXF:OTC; 56P:FRA) while raising his target price to CA$2.00, following the announcement of a US$150 million sale of a 40% working interest in its Sinu-9 Block to Maurel & Prom (M&P).
The deal, expected to close in June/July 2025 with an effective date of February 1, 2025, allows the company to maintain a 32% working interest for future value. M&P joins Macquarie Group as a strategic partner, bringing technical expertise in developing greenfield natural gas fields.
The transaction metrics indicate M&P is paying CA$64,500 per boe/d and a 4.2x multiple of annualized operating income, based on Sinu-9 reaching 50 mmcf/d gross capacity in early Q2 2025. These metrics suggest M&P sees future upside potential.
With M&P taking over Sinu-9 operations, the company is expected to focus on its Maria Conchita Block, where infrastructure expansion should increase capacity to 25-30 mmcf/d gross. Additional capacity could be possible depending on results from the Aruchara-4 well, which is scheduled to spud later this quarter.
The analyst has revised forecasts, pushing Phase 2 infrastructure at Sinu-9 to early 2026 from Q4 2025. While growth is lower than previously modeled, production is expected to more than double this year with another near doubling in 2026. The US$150 million cash injection should provide a large surplus throughout the forecast period.
The revised CA$2.00 target price is derived from a 3.0x EV/DACF multiple of 2026 forecasts. The analyst notes that the transaction has lowered the company’s risk profile while maintaining considerable growth potential, with multiple options for the cash surplus including acquisitions, dividends, or share buybacks.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of NG Energy International Corp.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
Disclosures for Beacon Securities, NG Energy International Corp., January 21, 2025
Disclosure Requirements Does Beacon, or its affiliates or analysts collectively, beneficially own 1% or more of any class of the issuer’s equity securities? ☐ Yes ☒ No Does the analyst who prepared this research report have a position, either long or short, in any of the issuer’s securities? ☐ Yes ☒ No Has any director, partner, or officer of Beacon Securities, or the analyst involved in the preparation of the research report, received remuneration for any services provided to the securities issuer during the preceding 12 months? ☐ Yes ☒ No Has Beacon Securities performed investment banking services in the past 12 months and received compensation for investment banking services for this issuer in the past 12 months? ☒ Yes ☐ No Was the analyst who prepared this research report compensated from revenues generated solely by the Beacon Securities Investment Banking Department? ☐ Yes ☒ No Does any director, officer, or employee of Beacon Securities serve as a director, officer, or in any advisory capacity to the issuer? ☐ Yes ☒ No Are there any material conflicts of interest with Beacon Securities or the analyst who prepared the report and the issuer? ☐ Yes ☒ No Is Beacon Securities a market maker in the equity of the issuer? ☐ Yes ☒ No Has the analyst visited the issuer’s material operation (s)? ☒ Yes ☐ No Did the issuer pay for or reimburse the analyst for the travel expenses? ☐ Yes ☒ No All information contained herein has been collected and compiled by Beacon Securities Limited, an independently owned and operated member of the Canadian Investment Regulatory Organization (CIRO). All facts and statistical data have been obtained or ascertained from sources, which we believe to be reliable, but are not warranted as accurate or complete. All projections and estimates are the expressed opinion of Beacon Securities Limited, and are subject to change without notice. Beacon Securities Limited takes no responsibility for any errors or omissions contained herein, and accepts no legal responsibility from any losses resulting from investment decisions based on the content of this report. This report is provided for informational purposes only and does not constitute an offer or solicitation to buy or sell securities discussed herein. Based on their volatility, income structure, or eligibility for sale, the securities mentioned herein may not be suitable or available for all investors in all countries.
Dissemination Beacon Securities distributes its research products simultaneously, via email, to its authorized client base. All research is then available on www.beaconsecurities.ca via login and password. Analyst Certification The Beacon Securities Analyst named on the report hereby certifies that the recommendations and/or opinions expressed herein accurately reflect such research analyst’s personal views about the company and securities that are the subject of the report; or any other companies mentioned in the report that are also covered by the named analyst. In addition, no part of the research analyst’s compensation is, or will be, directly or indirectly, related to the specific recommendations or views expressed by such research analyst in this report.
( Companies Mentioned: GASX:TSX.V;GASXF:OTC;56P:FRA, )
Source: https://www.streetwisereports.com/article/2025/01/27/energy-co-gains-raised-target-price-after-announcement.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.